Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM)
Clinical trial NCT05749276 · RECRUITING
Trial details
- NCT number
- NCT05749276
- Sponsor
- Nantes University Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-06
- Primary completion
- 2028-08-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.